試す 金 - 無料
analytica Lab India focuses on innovative solutions
Chronicle Pharmabiz
|September 18, 2025
EVEN as the laboratory world is developing rapidly, analytica Lab India, the largest and most important platform for the analysis, laboratory-technology and biotechnology market in India, stands as a testimony to the growing prowess of these sectors.
-
Scheduled to take place from September 18 to 20, 2025 at HITEX Exhibition Centre, Hyderabad, analytica Lab India focuses on innovative and applied product and system solutions for laboratories in the industrial, research and science sectors. As the industry's definitive forum, fair and conference gather all relevant information about the latest developments.
As the industry’s most important marketplace, analytica Lab India brings together scientists, entrepreneurs and users from all over the world. India being one of the most promising markets of the future, participants would benefit from excellent business opportunities.
analytica Lab India, South Asia’s leading marketplace for laboratory technologies and analytical instruments, brings together international and domestic manufacturers, laboratory users, consultants, and key government officials on one platform, creating an ideal environment for networking and fostering business collaborations among industry professionals.
analytica Lab India is part of the global exhibition network, which includes analytica in Munich, analytica China, analytica Vietnam, and analytica Lab Africa.
This event happens twice in Mumbai & Hyderabad respectively. The Mumbai edition hosted over 165 exhibitors displaying 3000 products and solutions and attracted audience of over 6024 visitors across 3 days in 2024 edition.
The Hyderabad edition happened in co-location with Pharma Pro&Pack Epxo. These events together hosted over 528 exhibitors and attracted audience of over 24,533 visitors across 8 halls in the 2024 edition.
このストーリーは、Chronicle Pharmabiz の September 18, 2025 版からのものです。
Magzter GOLD を購読すると、厳選された何千ものプレミアム記事や、10,000 以上の雑誌や新聞にアクセスできます。
すでに購読者ですか? サインイン
Chronicle Pharmabiz からのその他のストーリー
Chronicle Pharmabiz
Home-grown CAR-T cell therapies gaining ground
INDIAN biotech and pharmaceutical companies are actively working on innovative solutions to make CART cell therapy both accessible and cost-effective.
4 mins
November 27, 2025
Chronicle Pharmabiz
NPPA extends price fixation on orthopaedic implants for 1 year
IN a move that will disappoint the industry, the National Pharmaceutical Pricing Authority (NPPA) has extended the ceiling price fixation it imposed on orthopaedic knee implants for knee replacement system for one more year.
1 mins
November 27, 2025
Chronicle Pharmabiz
FICCI envisages it's Smart AAMs to boost healthcare
In line with the Central Government's vision of comprehensive primary healthcare, FICCI Swasth Bharat Task Force has undertaken a transformative initiative titled 'Smart Ayushman Arogya Mandirs-AAMs' (earlier called Health & Wellness Centres) aimed at strengthening the primary healthcare delivery system across India.
1 min
November 27, 2025
Chronicle Pharmabiz
DoP asked to bring policy for affordable drug pricing
THE Parliamentary Panel on Chemicals and Fertilisers has recommended to the Department of Pharmaceutical (DoP) to take steps to come out with a pharmaceutical policy with thrust to provide both scheduled and nonscheduled formulations at affordable prices.
1 mins
November 27, 2025
Chronicle Pharmabiz
Ramaiah emphasises need for bone health and osteoporosis diagnosis
RAMAIAH Memorial Hospital (RMH), a multi-superspecialty quaternary care hospitals emphasises on bone health and osteoporosis diagnosis. It calls for timely screening and diagnosis through the new and advanced DXA scanner with superior and accurate test results.
2 mins
November 27, 2025
Chronicle Pharmabiz
Nathealth calls for action in 2026-27 Union Budget
NATHEALTH has submitted its budget 2026-27 recommendations to the Union government, outlining a roadmap to strengthen healthcare delivery, foster innovation, and expand insurance and preventive coverage.
1 mins
November 27, 2025
Chronicle Pharmabiz
Hotspots & growth opportunities in biomanufacturing
THE Indian bioeconomy has grown from US$ 10 billion in 2014 to US$ 165.7 billion in 2024, and is likely reach US$ 300 billion by 2030.
3 mins
November 27, 2025
Chronicle Pharmabiz
Omega Hospitals acquires Cytecare Hospitals
Morgan Stanley PE backed Hyderabad-based Omega Hospitals has acquired Cytecare Hospitals, a leading cancer care hospital in Bengaluru.
2 mins
November 27, 2025
Chronicle Pharmabiz
Devices sector hails withdrawal of QCOs
THE medical devices manufacturers industry in the country has welcomed the Central government's decision to withdraw multiple Quality Control Orders (QCOs) imposed on essential raw materials across various industries, including the medical devices sector.
1 min
November 27, 2025
Chronicle Pharmabiz
'There is urgent need for tech-focused regulatory approach for med devices'
THE Indian healthcare industry has evolved at a breakneck pace, but its regulatory framework has struggled to keep up to its speed of development.
2 mins
November 27, 2025
Listen
Translate
Change font size
